Clinical Transplants 2013 Individual Chapter Downloads
2013 Annual Literature Review of Donor-specific HLA Antibodies After Organ Transplantation.
2013 Annual Literature Review of Donor-specific HLA Antibodies After Organ Transplantation. Kan..
$5.00
2013 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): Current Uses and Outcomes of Hematopoietic Cell Transplants for Blood and Bone Marrow Disorders.
2013 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): Current..
$5.00
A Common Blood Gene Assay Predates Clinical and Histological Rejection in Kidney and Heart Allografts.
A Common Blood Gene Assay Predates Clinical and Histological Rejection in Kidney and Heart Allograft..
$5.00
A Critical Analysis of Quantitating Flow Cytometry: The Role of the Crossmatch in 2014.
A Critical Analysis of Quantitating Flow Cytometry: The Role of the Crossmatch in 2014. Rosenbe..
$5.00
A Regulated System of Incentives for Living Kidney Donation: Why Can't We Agree to Do a Trial?
A Regulated System of Incentives for Living Kidney Donation: Why Can't We Agree to Do a Trial? ..
$5.00
ABO-incompatible Kidney Transplantation: Long-Term Outcomes.
ABO-incompatible Kidney Transplantation: Long-Term Outcomes. Tanabe K, Ishida H, Inui M, Okumi ..
$5.00
Anti-HLA-E Monoclonal Antibodies Reacting with HLA-1a and 1b Alleles Like IVIg as Potential IVIg-Immunomimetics: An Evolving Therapeutic Concept.
Anti-HLA-E Monoclonal Antibodies Reacting with HLA-1a and 1b Alleles Like IVIg as Potential IVIg-Imm..
$5.00
Antibodies Against "Danger" in the Dynamic of Post-transplant Circulation.
Antibodies Against "Danger" in the Dynamic of Post-transplant Circulation. Taniguchi M.Clinical..
$5.00
Can We Use Dilution-titration Studies to Identify Clinically Relevant HLA Antibody Specificities?
Can We Use Dilution-titration Studies to Identify Clinically Relevant HLA Antibody Specificities?&nb..
$5.00
Causes of Graft Failure in Simultaneous Pancreas-Kidney Transplantation by Various Time Periods.
Causes of Graft Failure in Simultaneous Pancreas-Kidney Transplantation by Various Time Periods.&nbs..
$5.00
Cells Versus Antibodies in Allograft Destruction - A Historical Perspective.
Cells Versus Antibodies in Allograft Destruction - A Historical Perspective. Brent L.Clinical T..
$5.00
Clinical Relevance of Pre- and Post-Transplant HLA Antibodies, Donor-specific, and Nondonor-specific HLA Antibodies Detected by ELISA in Renal Transplantation.
Clinical Relevance of Pre- and Post-Transplant HLA Antibodies, Donor-specific, and Nondonor-specific..
$5.00
Clinical Strategy for Induction of Transplantation Tolerance Through Mixed Chimerism.
Clinical Strategy for Induction of Transplantation Tolerance Through Mixed Chimerism. Cosimi AB..
$5.00
Desensitization in the Era of Kidney Paired Donation: The Mayo Foundation 3-site Experience.
Desensitization in the Era of Kidney Paired Donation: The Mayo Foundation 3-site Experience. Sc..
$5.00
Donor Risk Factors in Orthotopic Liver Transplant: Analysis of the OPTN/UNOS Registry.
Donor Risk Factors in Orthotopic Liver Transplant: Analysis of the OPTN/UNOS Registry. Kawakita..
$5.00
Donor Specific Antibodies Before and After Kidney Transplant: The University of Colorado Experience.
Donor Specific Antibodies Before and After Kidney Transplant: The University of Colorado Experience...
$5.00
Evolution of Studies of HLA Class I Antigen Processing Machinery (APM) Components in Malignant Cells.
Evolution of Studies of HLA Class I Antigen Processing Machinery (APM) Components in Malignant Cells..
$5.00
Evolving Concepts in Desensitization.
Evolving Concepts in Desensitization. Jordan SC, Vo AA.Clinical Transplants 2013, Chapter 34Abs..
$5.00
Excellent Outcomes with Expanded Criteria Donor Kidneys: The Role of the Recipient's Age.
Excellent Outcomes with Expanded Criteria Donor Kidneys: The Role of the Recipient's Age. Serur..
$5.00
Exchange Donor Renal Transplantation.
Exchange Donor Renal Transplantation. Kim SJ, Kim MS, Park K.Clinical Transplants 2013, Chapter..
$5.00
Fifteen Years Later: Main Lessons from Composite Tissue Allografts.
Fifteen Years Later: Main Lessons from Composite Tissue Allografts. Dubernard JM, Sirigu A, Seu..
$5.00
Fifty Years Later.
Fifty Years Later. Mangan TL, Benedetti KA, Starzl TE.Clinical Transplants 2013, Chapter 11Abst..
$5.00
Gene and Stem Cell Therapy for Diabetes.
Gene and Stem Cell Therapy for Diabetes. Calne RY, Ghoneim MA, Lee KO, Uin GS.Clinical Transpla..
$5.00
Heart Transplantation in an Aging Society: An Analysis of 25 Years of the OPTN/UNOS Registry.
Heart Transplantation in an Aging Society: An Analysis of 25 Years of the OPTN/UNOS Registry. H..
$5.00
HLA Identical Non-Chimeric and HLA Disparate Chimeric Renal Transplant Tolerance.
HLA Identical Non-Chimeric and HLA Disparate Chimeric Renal Transplant Tolerance. Leventhal JR,..
$5.00
HLA in Anthropology: The Enigma of Easter Island.
HLA in Anthropology: The Enigma of Easter Island. Sanchez-Mazas A, Thorsby E.Clinical Transplan..
$5.00
HLA Matching and Kidney Transplantation: Beyond Graft Survival.
HLA Matching and Kidney Transplantation: Beyond Graft Survival. Opelz G, Döhler B.Clinical Tran..
$5.00
HLA Matching at the Epitope Level: The Way to Go.
HLA Matching at the Epitope Level: The Way to Go. Duquesnoy RJ.Clinical Transplants 2013, Chapt..
$5.00
HLA-specific Antibody Distribution in Renal Transplant Waiting List Patients: Utility of Antigen Frequency Data in the Definition of HLA-reactive Epitopes.
HLA-specific Antibody Distribution in Renal Transplant Waiting List Patients: Utility of Antigen Fre..
$5.00
Immunoglobulin G Subclass Analysis of HLA Donor Specific Antibodies in Heart and Renal Transplant Recipients.
Immunoglobulin G Subclass Analysis of HLA Donor Specific Antibodies in Heart and Renal Transplant Re..
$5.00
Immunoregulation and Allogenicity in Cardiac Stem Cell Regenerative Therapy.
Immunoregulation and Allogenicity in Cardiac Stem Cell Regenerative Therapy. Charron D, Al-Dacc..
$5.00
Impact of Solid Phase Antibody Testing on Organ Allocation in the United States.
Impact of Solid Phase Antibody Testing on Organ Allocation in the United States. Reinsmoen NL.C..
$5.00
Incidence and Hazards of Alloantibodies in Renal Transplantation.
Incidence and Hazards of Alloantibodies in Renal Transplantation. Everly MJ.Clinical Transplant..
$5.00
Kidney Failure Requiring Kidney Transplantation After Pancreas Transplant Alone.
Kidney Failure Requiring Kidney Transplantation After Pancreas Transplant Alone. Nata N, Huang ..
$5.00
Living Donor Kidney Transplantation: "Beauty and the Beast"!
Living Donor Kidney Transplantation: "Beauty and the Beast"! Danovitch GM.Clinical Transplants ..
$5.00
Novel Biomarker Combination Predicts Long-term Allograft Outcome.
Novel Biomarker Combination Predicts Long-term Allograft Outcome. Cail J, Huang W, Terasaki PI,..
$5.00
Novel Strategies for Immunological Monitoring of Kidney Transplant Recipients: From Microrna to Alloantibodies.
Novel Strategies for Immunological Monitoring of Kidney Transplant Recipients: From Microrna to Allo..
$5.00
Plasma Cell Biology: Principles for Therapeutic Design.
Plasma Cell Biology: Principles for Therapeutic Design. Woodle ES, Alloway RR, Ejaz NS.Clinical..
$5.00
Post-Transplant Development of C1q-positive HLA Antibodies and Kidney Graft Survival.
Post-Transplant Development of C1q-positive HLA Antibodies and Kidney Graft Survival. Piazza A,..
$5.00
Pre-Nephrectomy Angiotensin II Type 1 Receptor Antibodies in Living Kidney Donors: A Concern?
Pre-Nephrectomy Angiotensin II Type 1 Receptor Antibodies in Living Kidney Donors: A Concern? H..
$5.00
Pre-Transplant Angiotensin II Type 1 Receptor Antibodies: A Risk Factor for Decreased Kidney Graft Function in the Early Post-transplant Period?
Pre-Transplant Angiotensin II Type 1 Receptor Antibodies: A Risk Factor for Decreased Kidney Graft F..
$5.00
Progress and Outcomes of the First High-volume Pediatric Liver Transplantation Program in Saudi Arabia.
Progress and Outcomes of the First High-volume Pediatric Liver Transplantation Program in Saudi Arab..
$5.00
Reduction of HLA Class I Expression by Ribonucleic Acid Interference Mitigates Allogenicity of Human Primary and Immortalized Cells.
Reduction of HLA Class I Expression by Ribonucleic Acid Interference Mitigates Allogenicity of Human..
$5.00
Reflections on the Unique Tolerogenicity of Bone Marrow, the Enigma of Chimerism and Clinical Tolerance.
Reflections on the Unique Tolerogenicity of Bone Marrow, the Enigma of Chimerism and Clinical Tolera..
$5.00
Report from the Japan Registry of Pancreas Transplantation (2000-2012): Outcomes of Pancreas Transplantation from Marginal Donors.
Report from the Japan Registry of Pancreas Transplantation (2000-2012): Outcomes of Pancreas Transpl..
$5.00
Role of Alloimmunity and Autoimmunity in Allograft Rejection.
Role of Alloimmunity and Autoimmunity in Allograft Rejection. Banan B, Xu Z, Gunasekaran M, Moh..
$5.00
Statins in Heart Transplantation.
Statins in Heart Transplantation. Kittleson MM, Kobashigawa JA.Clinical Transplants 2013, Chapt..
$5.00
The Big Picture: A Case Report of Antibody Mediated Rejection and Treatment After Lung Transplantation Illustrating the Need to Correlate Laboratory Findings with Clinical Status.
The Big Picture: A Case Report of Antibody Mediated Rejection and Treatment After Lung Transplantati..
$5.00
The Differential Pathogenicity of HLA Antibodies: What a Large Cross-sectional Study Can Tell Us.
The Differential Pathogenicity of HLA Antibodies: What a Large Cross-sectional Study Can Tell Us.&nb..
$5.00
The Non-classical Antigens of HLA-G and HLA-E as Diagnostic and Prognostic Biomarkers and as Therapeutic Targets in Transplantation and Tumors.
The Non-classical Antigens of HLA-G and HLA-E as Diagnostic and Prognostic Biomarkers and as Therape..
$5.00
Transplantation in Turkey.
Transplantation in Turkey. Haberal M.Clinical Transplants 2013, Chapter 20AbstractThe cornersto..
$5.00
Understanding Recurrent Glomerulonephritis in Renal Transplants: 50 Years of Progress.
Understanding Recurrent Glomerulonephritis in Renal Transplants: 50 Years of Progress. Glassock..
$5.00
Understanding Trends and Predictors of Outcome in Elderly Renal Transplant Recipients: An Analysis of the UNOS Registry.
Understanding Trends and Predictors of Outcome in Elderly Renal Transplant Recipients: An Analysis o..
$5.00
Unravelling the Connections Between Donor Specific Antibodies and Renal Allograft Pathology.
Unravelling the Connections Between Donor Specific Antibodies and Renal Allograft Pathology. Ch..
$5.00
View from a Living Donor.
View from a Living Donor. Fehrman-Ekholm I.Clinical Transplants 2013, Chapter 21SummaryLiving k..
$5.00